Business · 02/07/2019
FDA Releases Draft Guidance on Instructions for Use Labeling for Human Prescription Drugs and Biological Products
The US Food and Drug Administration (FDA) has released a draft guidance for industry on Instructions for Use (IFU) labeling for human prescription drugs and biological products, aiming to standardize content and format for patient instructions and ensure clear, concise information for safe and effective use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →